Amyloidosis in Alzheimer's disease: Pathogeny, etiology, and related therapeutic directions

C Ma, F Hong, S Yang - Molecules, 2022 - mdpi.com
The amyloid hypothesis of Alzheimer's disease has long been the predominant theory,
suggesting that Alzheimer's disease is caused by the accumulation of amyloid beta protein …

Liver X receptors in lipid signalling and membrane homeostasis

B Wang, P Tontonoz - Nature Reviews Endocrinology, 2018 - nature.com
Liver X receptors α and β (LXRα and LXRβ) are nuclear receptors with pivotal roles in the
transcriptional control of lipid metabolism. Transcriptional activity of LXRs is induced in …

Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease

F Liao, H Yoon, J Kim - Current opinion in lipidology, 2017 - journals.lww.com
Emerging data suggest that ApoE affects several amyloid β-independent pathways. These
underexplored pathways may provide new insights into Alzheimer's disease pathogenesis …

LXR regulation of brain cholesterol: from development to disease

R Courtney, GE Landreth - Trends in Endocrinology & Metabolism, 2016 - cell.com
Liver X receptors (LXRs) are master regulators of cholesterol homeostasis and inflammation
in the central nervous system (CNS). The brain, which contains a disproportionately large …

Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE

X Zhang, T Yuan, X Chen, X Liu, J Hu, Z Liu - Progress in Lipid Research, 2024 - Elsevier
The prevalence of Alzheimer's disease (AD) continues to rise due to the increasing aging
population. Among the various genetic factors associated with AD, apolipoprotein E (ApoE) …

Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer's disease in a mouse model of Aβ amyloidosis

H Karahan, DC Smith, B Kim, LC Dabin… - Science …, 2021 - science.org
Recently, large-scale human genetics studies identified a rare coding variant in the ABI3
gene that is associated with an increased risk of Alzheimer's disease (AD). However …

Exploring the promise of targeting ubiquitin-proteasome system to combat Alzheimer's disease

A Al Mamun, MS Uddin, MT Kabir, S Khanum… - Neurotoxicity …, 2020 - Springer
The ubiquitin (Ub)-proteasome system (UPS) is considered as a central protein degradation
system in all eukaryotes. The UPS comprises of several factors such as Ub and Ub-like …

ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease

Y Li, JR Macyczko, CC Liu, G Bu - Neurobiology of aging, 2022 - Elsevier
APOE4 is the first identified genetic risk factor and remains as the strongest predictor for late-
onset Alzheimer's disease (AD). Studies of AD patients, AD patient-specific induced …

The ubiquitin system in Alzheimer's disease

LD Harris, S Jasem, JDF Licchesi - Proteostasis and Disease: From Basic …, 2020 - Springer
Alzheimer's disease (AD) is the most common form of dementia, most prevalent in the
elderly population and has a significant impact on individuals and their family as well as the …

The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease

Y Zhang, X Chen, Y Zhao, M Ponnusamy… - Reviews in the …, 2017 - degruyter.com
Alzheimer's disease (AD) is the most common neurodegenerative disorder leading to
dementia in the elderly population. AD is associated with the buildup of β-amyloid and tau …